Ironwood’s preparation for activist-driven R&D split puts 40 staffers out of work

Ironwood may have avoided sparring with activists by introducing an R&D split-off, but its employees paid the price. The Massachusetts drugmaker last week pink-slipped 40 workers, or about 6% of its total staff, according to an SEC filing